Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Predictive value of the clinically and scintigraphically important bone lesions in hormone-refractory prostate cancer (HRPC).

× No keyword cloud information.

17 in total

1. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan.

Authors: M S Soloway; S W Hardeman; D Hickey; J Raymond; B Todd; S Soloway; M Moinuddin
Journal: Cancer Date: 1988-01-01 Impact factor: 6.860

2. Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.

Authors: F Kraeber-Bodéré; L Campion; C Rousseau; S Bourdin; J F Chatal; I Resche
Journal: Eur J Nucl Med Date: 2000-10

3. Patterns of bone metastasis and their prognostic significance in patients with carcinoma of the prostate.

Authors: A Rana; G D Chisholm; M Khan; S S Sekharjit; M V Merrick; R A Elton
Journal: Br J Urol Date: 1993-12

4. Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: comparison with the extent of disease (EOD) grade.

Authors: S Akimoto; Y Furuya; K Akakura; J Shimazaki; H Ito
Journal: Prostate Date: 1999-01-01 Impact factor: 4.104

5. Prognostic significance of bone metastases in patients with metastatic prostate cancer.

Authors: K Yamashita; K Denno; T Ueda; Y Komatsubara; T Kotake; M Usami; O Maeda; S Nakano; Y Hasegawa
Journal: Cancer Date: 1993-02-15 Impact factor: 6.860

6. Prognostic significance of pelvic recurrence and distant metastasis in prostate carcinoma following definitive radiotherapy.

Authors: P P Lai; C A Perez; M A Lockett
Journal: Int J Radiat Oncol Biol Phys Date: 1992 Impact factor: 7.038

7. Analysis of prognostic factors in men with metastatic prostate cancer. Uro-Oncology Group of Northern Alberta.

Authors: D S Ernst; J Hanson; P M Venner
Journal: J Urol Date: 1991-08 Impact factor: 7.450

8. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

Authors: Howard I Scher; Susan Halabi; Ian Tannock; Michael Morris; Cora N Sternberg; Michael A Carducci; Mario A Eisenberger; Celestia Higano; Glenn J Bubley; Robert Dreicer; Daniel Petrylak; Philip Kantoff; Ethan Basch; William Kevin Kelly; William D Figg; Eric J Small; Tomasz M Beer; George Wilding; Alison Martin; Maha Hussain
Journal: J Clin Oncol Date: 2008-03-01 Impact factor: 44.544

9. A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index.

Authors: M Imbriaco; S M Larson; H W Yeung; O R Mawlawi; Y Erdi; E S Venkatraman; H I Scher
Journal: Clin Cancer Res Date: 1998-07 Impact factor: 12.531

Review 10. Percentage of the positive area of bone metastasis is an independent predictor of disease death in advanced prostate cancer.

Authors: M Noguchi; H Kikuchi; M Ishibashi; S Noda
Journal: Br J Cancer Date: 2003-01-27 Impact factor: 7.640